ZM-012

N/A

Report date: 2023/08/11 18:00:19

Base Information

Drug NameZM-012
Drug Alias NameZM-012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsNatural killer cell receptors modulators
TargetsNatural killer cell receptors
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZumutor Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZumutor Biologics Inc
Inactive CompaniesN/A
Active IndicationsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A